Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes

11Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The relationship between serial changes in soluble tumor necrosis factor receptor type 1 (TNFR1) levels and an early decline in estimated glomerular filtration rate (eGFR) decline remains to be defined. We found that in patients with an early decline in renal function (n = 30), soluble TNFR1 values increased (2,595 ± 683 vs 3,596 ± 1,203 pg/mL, P < 0.001) as eGFR decreased (89 ± 1 vs 51 ± 2 mL/min/1.73m2, P < 0.001) over an 8-year period. In contrast, there were no significant changes in soluble TNFR1 levels in patients with stable renal function (n = 17). In a multilevel mixed effects regression model, changes in soluble TNFR1 levels were found to be independently associated with eGFR decline (Z = −4.31, P < 0.001). An early decline in eGFR is associated with an increase in soluble TNFR levels; however, the factors driving this increase and the possible pathological role that soluble TNFR1 plays in progressive diabetic kidney disease remain to be determined.

Author supplied keywords

Cite

CITATION STYLE

APA

MacIsaac, R. J., Farag, M., Obeyesekere, V., Clarke, M., Boston, R., Ward, G. M., … Ekinci, E. I. (2019). Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes. Journal of Diabetes Investigation, 10(6), 1537–1542. https://doi.org/10.1111/jdi.13061

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free